NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $99,560 | -95.1% | 26,200 | -93.0% | 0.00% | -92.3% |
| Q1 2022 | $2,021,067 | -11.9% | 374,966 | +120.9% | 0.01% | -7.1% |
| Q4 2021 | $2,292,998 | +568.1% | 169,726 | +748.6% | 0.01% | +600.0% |
| Q2 2021 | $343,200 | -69.3% | 20,000 | -61.4% | 0.00% | -77.8% |
| Q4 2019 | $1,119,000 | -88.5% | 51,835 | -81.1% | 0.01% | -87.3% |
| Q2 2019 | $9,761,000 | +3277.5% | 274,319 | +3089.8% | 0.07% | +3450.0% |
| Q1 2019 | $289,000 | -76.9% | 8,600 | -77.4% | 0.00% | -80.0% |
| Q4 2018 | $1,252,000 | -73.0% | 38,100 | -50.0% | 0.01% | -66.7% |
| Q3 2018 | $4,645,000 | +221.5% | 76,192 | +157.5% | 0.03% | +275.0% |
| Q2 2018 | $1,445,000 | +21.0% | 29,585 | +47.9% | 0.01% | +33.3% |
| Q4 2017 | $1,194,000 | -15.3% | 20,000 | -80.5% | 0.01% | -25.0% |
| Q1 2016 | $1,410,000 | +464.0% | 102,600 | +593.2% | 0.01% | +700.0% |
| Q4 2015 | $250,000 | -68.6% | 14,800 | -79.6% | 0.00% | -75.0% |
| Q3 2015 | $795,000 | +2641.4% | 72,496 | +3052.0% | 0.00% | – |
| Q2 2015 | $29,000 | -96.9% | 2,300 | -97.3% | 0.00% | -100.0% |
| Q1 2015 | $941,000 | +19.3% | 85,500 | +67.9% | 0.01% | 0.0% |
| Q4 2014 | $789,000 | +124.1% | 50,916 | +85.4% | 0.01% | +66.7% |
| Q2 2014 | $352,000 | -63.6% | 27,467 | -70.4% | 0.00% | -70.0% |
| Q3 2013 | $968,000 | -77.7% | 92,645 | -75.3% | 0.01% | -78.7% |
| Q2 2013 | $4,339,000 | – | 375,668 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |